Here, we also used a small molecule inhibitor targeting the JAK–STAT signalling pathway to verify whether inhibiting the JAK–STAT signalling pathway could reverse the 5‐Fu resistance of CRC cells [48]. Here, SOAT1 is linked to colorectal carcinoma.